1. Home
  2. AAPG vs ASAN Comparison

AAPG vs ASAN Comparison

Compare AAPG & ASAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • ASAN
  • Stock Information
  • Founded
  • AAPG 2009
  • ASAN 2008
  • Country
  • AAPG China
  • ASAN United States
  • Employees
  • AAPG N/A
  • ASAN N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • ASAN Retail: Computer Software & Peripheral Equipment
  • Sector
  • AAPG Health Care
  • ASAN Technology
  • Exchange
  • AAPG Nasdaq
  • ASAN Nasdaq
  • Market Cap
  • AAPG 3.2B
  • ASAN 3.1B
  • IPO Year
  • AAPG 2025
  • ASAN 2020
  • Fundamental
  • Price
  • AAPG $38.24
  • ASAN $13.97
  • Analyst Decision
  • AAPG Buy
  • ASAN Hold
  • Analyst Count
  • AAPG 1
  • ASAN 16
  • Target Price
  • AAPG N/A
  • ASAN $16.70
  • AVG Volume (30 Days)
  • AAPG 12.4K
  • ASAN 3.6M
  • Earning Date
  • AAPG 08-06-2025
  • ASAN 09-02-2025
  • Dividend Yield
  • AAPG N/A
  • ASAN N/A
  • EPS Growth
  • AAPG N/A
  • ASAN N/A
  • EPS
  • AAPG N/A
  • ASAN N/A
  • Revenue
  • AAPG $134,352,180.00
  • ASAN $738,695,000.00
  • Revenue This Year
  • AAPG N/A
  • ASAN $10.27
  • Revenue Next Year
  • AAPG $389.09
  • ASAN $8.90
  • P/E Ratio
  • AAPG N/A
  • ASAN N/A
  • Revenue Growth
  • AAPG 341.77
  • ASAN 9.84
  • 52 Week Low
  • AAPG $16.50
  • ASAN $11.05
  • 52 Week High
  • AAPG $43.58
  • ASAN $27.77
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • ASAN 46.67
  • Support Level
  • AAPG N/A
  • ASAN $13.18
  • Resistance Level
  • AAPG N/A
  • ASAN $14.95
  • Average True Range (ATR)
  • AAPG 0.00
  • ASAN 0.49
  • MACD
  • AAPG 0.00
  • ASAN 0.24
  • Stochastic Oscillator
  • AAPG 0.00
  • ASAN 64.36

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About ASAN Asana Inc.

Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.

Share on Social Networks: